Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
B02BD Blood coagulation factors
B02BD15 Valoctocogene roxaparvovec
D12434 Valoctocogene roxaparvovec (USAN/INN) <US>
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
DG02013 Blood coagulation factor
D12434 Valoctocogene roxaparvovec
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Complement and coagulation
F8* [HSA_VAR:2157v1]
D12434 Valoctocogene roxaparvovec (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
Cellular and gene therapy products
D12434
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12434
Cellular and gene therapy products
D12434
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12434